Richard A. Bierly

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Protein Sciences Corp. engages in developing and manufacturing recombinant human and veterinary vaccines, therapeutics and diagnostics. The firm develops vaccines for influenza, SARS and other diseases. The company was founded by Mark A. Cochran and Franklin Volvovitz in 1983 and is headquartered in Meriden, CT.

Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ.

Ulthera, Inc. provides ultrasound therapy under the Ultherapy brand. It focuses on ultrasound imaging to to deliver its collagen-boosting treatment. The company was founded by Peter G. Barthe, Inder Raj S. Makin, Brain D. Oconner, Lana Slayton, and Michael H. Slayto n in April 2004 and is headquartered in Raleigh, NC.

Merz North America, Inc. operates as an specialty healthcare company. It offers treatment solutions for aesthetics, dermatology and neurosciences. The company was founded in 1908 and is headquartered in Raleigh, NC.

Onpharma, Inc. provides pharmaceutical services. The firm offers dispensing devices for anesthetic use. Its products include Onpharma Mixing Pen, Onpharma Cartridge Connectors, and Onset Sodium Bicarbonate Injection. The company was dounded by Matt J. Stepovich and Mic Falke in 2005 and is headquartered in Carson City, NV.

OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA.

Isosceles Pharmaceuticals, Inc. is a preclinical stage biotechnology and medical device company that focuses on delivering drug master file backed synthetic cannabinoids for their anti-inflammatory and pain relief properties. The private company is based in Wilmington, NC. The company's proprietary formulations, coupled with unique delivery platforms, provide high bioavailability via parenteral and transdermal routes. Isosceles Pharmaceuticals is a specialty pharmaceutical company with a pipeline of parenteral products designed to target the unmet need of novel non-opioid, non-NSAID analgesics to treat acute pain. William D. Humphries has been the CEO of the company since 2021.

Bryn Pharma LLC engages in the provision of emergency allergy drug cabinets. The company was founded in 2017 and is headquartered in Beverly Hills, CA.

Merz Pharmaceuticals LLC manufactures dermatology and podiatry products for skin foot and nail care. Its products include Mederma, which is used to treat scarring, Appearex and Erygel, which treats weak and brittle nails. The company is headquartered in Greensboro, NC.

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Part of Moderna, Inc., Onkaido Therapeutics LLC offers advancement of oncology products for previously undruggable targets and as a superior alternative to existing drug modalities. The private company is based in Cambridge, MA.

Circle Pharma, Inc. provides biotechnology services. The company was founded by Matthew P. Jacobson and Scott Lokey in June 2014 and is headquartered in San Francisco, CA.

Alcami Corp. Inc, provides chemistry-based outsourcing services to the pharmaceutical and biotechnology industries. It produces pharmaceutical intermediates and active pharmaceutical ingredients from early preclinical development to commercial manufacturing. The company was founded by Michael W. Major in 1999 and is headquartered in Wilmington, NC.

Merz Pharma Canada Ltd. engages in the research and market of drugs for treatment of neurological and psychiatric diseases. Its products include Belotero, Radiesse, Ultherapy, Xeomin, Neocutis, and Mederma. The company was founded in 2009 and is headquartered in Burlington, Canada.

Frazier Life Sciences Management LP (Frazier Life Sciences) is a private investment manager headquartered in Menlo Park, California. The firm was founded in 2021 as a newly spun off company from Frazier Management LLC. They are principally owned by Jamie Topper and Patrick Heron. Frazier Life Sciences provides discretionary investment management services to US private investment funds, Frazier Life Sciences Funds.

Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA.

KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom.